300 related articles for article (PubMed ID: 33972760)
1. Bioorthogonal catalytic patch.
Chen Z; Li H; Bian Y; Wang Z; Chen G; Zhang X; Miao Y; Wen D; Wang J; Wan G; Zeng Y; Abdou P; Fang J; Li S; Sun CJ; Gu Z
Nat Nanotechnol; 2021 Aug; 16(8):933-941. PubMed ID: 33972760
[TBL] [Abstract][Full Text] [Related]
2. In-Cell Dual Drug Synthesis by Cancer-Targeting Palladium Catalysts.
Clavadetscher J; Indrigo E; Chankeshwara SV; Lilienkampf A; Bradley M
Angew Chem Int Ed Engl; 2017 Jun; 56(24):6864-6868. PubMed ID: 28485835
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Efficiency of Pd(0)-Based Single Chain Polymeric Nanoparticles for
Deng L; Sathyan A; Adam C; Unciti-Broceta A; Sebastian V; Palmans ARA
Nano Lett; 2024 Feb; 24(7):2242-2249. PubMed ID: 38346395
[TBL] [Abstract][Full Text] [Related]
4. Rational Utilization of Black Phosphorus Nanosheets to Enhance Palladium-Mediated Bioorthogonal Catalytic Activity for Activation of Therapeutics.
Rong M; Liu J; Sun Z; Li T; Li Y; Jiang C; Lu L
Angew Chem Int Ed Engl; 2023 May; 62(19):e202216822. PubMed ID: 36917027
[TBL] [Abstract][Full Text] [Related]
5. Bioorthogonal strategies for the in vivo synthesis or release of drugs.
Lozhkin B; Ward TR
Bioorg Med Chem; 2021 Sep; 45():116310. PubMed ID: 34365101
[TBL] [Abstract][Full Text] [Related]
6. Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation.
Miller MA; Mikula H; Luthria G; Li R; Kronister S; Prytyskach M; Kohler RH; Mitchison T; Weissleder R
ACS Nano; 2018 Dec; 12(12):12814-12826. PubMed ID: 30550257
[TBL] [Abstract][Full Text] [Related]
7. Progress in controllable bioorthogonal catalysis for prodrug activation.
Liu X; Huang T; Chen Z; Yang H
Chem Commun (Camb); 2023 Oct; 59(84):12548-12559. PubMed ID: 37791560
[TBL] [Abstract][Full Text] [Related]
8. Bioorthogonal Uncaging of Cytotoxic Paclitaxel through Pd Nanosheet-Hydrogel Frameworks.
Pérez-López AM; Rubio-Ruiz B; Valero T; Contreras-Montoya R; Álvarez de Cienfuegos L; Sebastián V; Santamaría J; Unciti-Broceta A
J Med Chem; 2020 Sep; 63(17):9650-9659. PubMed ID: 32787091
[TBL] [Abstract][Full Text] [Related]
9. Efficient Palladium-Triggered Release of Vorinostat from a Bioorthogonal Precursor.
Rubio-Ruiz B; Weiss JT; Unciti-Broceta A
J Med Chem; 2016 Nov; 59(21):9974-9980. PubMed ID: 27786474
[TBL] [Abstract][Full Text] [Related]
10. Integration of Palladium Nanoparticles with Surface Engineered Metal-Organic Frameworks for Cell-Selective Bioorthogonal Catalysis and Protein Activity Regulation.
Chen X; Cai W; Liu J; Mao L; Wang M
ACS Appl Mater Interfaces; 2022 Mar; 14(8):10117-10124. PubMed ID: 35179352
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable nanoemulsion-based bioorthogonal nanocatalysts for intracellular generation of anticancer therapeutics.
Nabawy A; Gupta A; Jiang M; Hirschbiegel CM; Fedeli S; Chattopadhyay AN; Park J; Zhang X; Liu L; Rotello VM
Nanoscale; 2023 Aug; 15(33):13595-13602. PubMed ID: 37554065
[TBL] [Abstract][Full Text] [Related]
12. Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis.
Sancho-Albero M; Rubio-Ruiz B; Pérez-López AM; Sebastián V; Martín-Duque P; Arruebo M; Santamaría J; Unciti-Broceta A
Nat Catal; 2019 Oct; 2(10):864-872. PubMed ID: 31620674
[TBL] [Abstract][Full Text] [Related]
13. A minimally-masked inactive prodrug of panobinostat that is bioorthogonally activated by gold chemistry.
Rubio-Ruiz B; Pérez-López AM; Sebastián V; Unciti-Broceta A
Bioorg Med Chem; 2021 Jul; 41():116217. PubMed ID: 34022529
[TBL] [Abstract][Full Text] [Related]
14. Degradable ZnS-Supported Bioorthogonal Nanozymes with Enhanced Catalytic Activity for Intracellular Activation of Therapeutics.
Zhang X; Lin S; Huang R; Gupta A; Fedeli S; Cao-Milán R; Luther DC; Liu Y; Jiang M; Li G; Rondon B; Wei H; Rotello VM
J Am Chem Soc; 2022 Jul; 144(28):12893-12900. PubMed ID: 35786910
[TBL] [Abstract][Full Text] [Related]
15. Intracellular Catalysis with Selected Metal Complexes and Metallic Nanoparticles: Advances toward the Development of Catalytic Metallodrugs.
Soldevila-Barreda JJ; Metzler-Nolte N
Chem Rev; 2019 Jan; 119(2):829-869. PubMed ID: 30618246
[TBL] [Abstract][Full Text] [Related]
16. Inorganic nanoparticles as scaffolds for bioorthogonal catalysts.
Hirschbiegel CM; Zhang X; Huang R; Cicek YA; Fedeli S; Rotello VM
Adv Drug Deliv Rev; 2023 Apr; 195():114730. PubMed ID: 36791809
[TBL] [Abstract][Full Text] [Related]
17. A DNA-Gated and Self-Protected Bioorthogonal Catalyst for Nanozyme-Assisted Safe Cancer Therapy.
Zhang Y; Zhang L; Wang W; Deng Q; Liu M; Zhu Z; Liu H; Ren J; Qu X
Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202306395. PubMed ID: 37268594
[TBL] [Abstract][Full Text] [Related]
18. Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells.
Wang F; Zhang Y; Du Z; Ren J; Qu X
Nat Commun; 2018 Mar; 9(1):1209. PubMed ID: 29572444
[TBL] [Abstract][Full Text] [Related]
19. Intracellular Activation of Anticancer Therapeutics Using Polymeric Bioorthogonal Nanocatalysts.
Zhang X; Landis RF; Keshri P; Cao-Milán R; Luther DC; Gopalakrishnan S; Liu Y; Huang R; Li G; Malassiné M; Uddin I; Rondon B; Rotello VM
Adv Healthc Mater; 2021 Mar; 10(5):e2001627. PubMed ID: 33314745
[TBL] [Abstract][Full Text] [Related]
20. Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach.
Weiss JT; Dawson JC; Macleod KG; Rybski W; Fraser C; Torres-Sánchez C; Patton EE; Bradley M; Carragher NO; Unciti-Broceta A
Nat Commun; 2014; 5():3277. PubMed ID: 24522696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]